Humboldt Fund, a venture fund established in 1899, focuses on investing in bio revolution companies in the BioTech and Nanotechnology sectors. Based in New York, the fund, led by partner Sebastian Bernales, targets companies at the Pre-Seed, Seed, and Series A stages. With 22 investments and 1 exit, Humboldt Fund has a portfolio that includes Cellino Biotech. For more information, visit their website at www.humboldtfund.com.